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Definition 
Pulmonary embolism (PE) is a potential cardiovascular 
emergency caused by a sudden blockage in a lung artery  by a 
blood clot(s) that has(ve) traveled in most cases, from the legs 
or, rarely, other parts of the body (deep vein thrombosis)  
through the bloodstream (embolism) with symptoms and 
signs that may include shortness of breath, rapid 
breathing, rapid heart rate, chest pain particularly upon 
breathing in, coughing up blood, low blood oxygen 
levels, fever, (in severe cases)  abnormally low blood pressure, 
passing out, and sudden death, with rare long-term 
complications in survived patients in form of  chronic 
thromboembolic pulmonary hypertension (CTEPH), leading to 
right heart failure. 
mayoclinic.org/diseases-conditions/pulmonary-embolism/home/ovc-20234736 en.wikipedia.org/wiki/Pulmonary_embolism 
Epidemiology 1 
• The exact number of people affected by deep venous 
thrombosis (DVT) and PE isn't known, estimates suggest 
these conditions affect 300,000 to 600,000 people in the 
United States and 430,000 people  in Europe each year  
• Rates are similar in males and females and become more 
common as people get older  
• If left untreated, about 30 percent of patients who have PE 
will die 
• Most of those who die do so within the first few hours of 
the event  
• A prompt diagnosis and proper treatment can save lives 
and help prevent the complications of PE. 
https://www.nhlbi.nih.gov/health/health-topics/topics/pe 
Epidemiology 2 
The majority of VTE events is asymptomatic; while some 
cases present with fatal PE. 
http://www.wikidoc.org/index.php/Pulmonary_embolism_epidemiology_and_demographics 
Epidemiology 3 
http://emedicine.medscape.com/article/167981-overview#a5 
Epidemiology 4 
http://www.nature.com/nrcardio/journal/v7/n10/images/nrcardio.2010.106-f2.jpg 
Risk Factors and Etiology 1 
http://www.healthline.com/health/pulmonary-embolus#Riskfactors3 
• Leg or pelvic vein thromboses (about 90% of 
emboli) 
• Cancer 
• A family history of embolisms 
• Fractures of the leg or hip 
• Hypercoagulable states or genetic blood clotting 
disorders, including factor V Leiden, prothrombin 
gene mutation, and elevated levels of homocysteine  
Risk Factors and Etiology 2 
http://www.healthline.com/health/pulmonary-embolus#Riskfactors3 
• A history of heart attack or stroke 
• Major surgery 
• Obesity 
• A sedentary lifestyle 
• Age over 60 years 
• Taking estrogen or testosterone. 
Risk Factors and Etiology 3               
Virchow's Triad 
https://en.wikipedia.org/wiki/Pulmonary_embolism#Risk_factors 
1. Alterations in blood flow: immobilization (after surgery), 
injury, pregnancy, obesity , cancer   
2. Factors in the vessel wall: surgery, catheterizations 
3. Factors affecting the properties of the blood: estrogen-
containing hormonal contraception, genetic thrombophilia 
(factor V Leiden, prothrombin mutation G20210A, protein 
C deficiency, protein S deficiency, antithrombin deficiency, 
hyperhomocysteinemia and plasminogen/fibrinolysis 
disorders), acquired thrombophilia (antiphospholipid 
syndrome, nephrotic syndrome, paroxysmal nocturnal 
hemoglobinuria), cancer (secretion of pro-coagulants). 
Mechanism 1 
• Although PE can arise from anywhere in the body, 
most commonly it arises from the calf veins 
• The venous thrombi predominately originate in 
venous valve pockets (inset) and at other sites of 
presumed venous stasis 
• Acute PE interferes with both the circulation and 
gas exchange 
• The manifestations of PE depend upon four main 
factors:  
– a) the extent of occlusion of the vascular tree  
http://emedicine.medscape.com/article/300901-overview 
Mechanism 2 
–b) the patient’s pre-existing cardiopulmonary 
condition   
– c) chemical vasoconstriction due to the release of 
serotonin and thromboxane from platelets that 
adhere to the embolus, as well as to fibropeptide 
B, which is a product of fibrinogen breakdown  
–d) the reflex vasoconstriction that is likely to 
occur as a consequence of pulmonary artery 
dilatation  
• Right ventricular (RV) failure due to pressure 
overload is the primary cause of death in severe PE.  
http://emedicine.medscape.com/article/300901-overview 
Mechanism 3 
http://www.pfizerindia.com/enewswebsite/images/image004.jpg 
Mechanism 4 
http://images.slideplayer.com/6/5661625/slides/slide_37.jpg 
Mechanism 5 
http://www.mayoclinic.org/diseases-conditions/pulmonary-embolism/symptoms-causes/dxc-20234744 
Mechanism 6 
http://eurheartj.oxfordjournals.org/content/35/43/3033 
Key factors contributing to hemodynamic collapse in 
acute PE. 
Mechanism 7                                           
Respiratory Consequences 
• Increased alveolar dead space 
• Hypoxemia 
• Hyperventilation 
• Regional loss of surfactant and pulmonary infarction 
• Arterial hypoxemia, that include ventilation-perfusion 
mismatch, intrapulmonary shunts, reduced cardiac output, 
and intracardiac shunt via a patent foramen ovale 
• Pulmonary infarction is an uncommon consequence 
because of the bronchial arterial collateral circulation. 
http://emedicine.medscape.com/article/300901-overview#a4 
Mechanism 8                                           
Hemodynamic Consequences 1 
• PE reduces the cross-sectional area of the pulmonary 
vascular bed, resulting in an increment in pulmonary 
vascular resistance, which, in turn, increases the right 
ventricular afterload 
• If the afterload is increased severely, right ventricular 
failure may ensue 
• The humoral and reflex mechanisms contribute to the 
pulmonary arterial constriction  
http://emedicine.medscape.com/article/300901-overview#a4 
Mechanism 9                                          
Hemodynamic Consequences 2 
• Following the initiation of anticoagulant therapy, the 
resolution of emboli usually occurs rapidly during the first 2 
weeks of therapy; however, it can persist on chest imaging 
studies for months to years 
• Chronic pulmonary hypertension may occur with failure of 
the initial embolus to undergo lyses or in the setting of 
recurrent thromboemboli. 
http://emedicine.medscape.com/article/300901-overview#a4 
Clinical data 1 
A 32-year-old man, having recently been diagnosed 
with a lower respiratory tract infection by his general 
practitioner, presented to the accident and 
emergency at 02:00 h with worsening shortness of 
breath. 
Clinical data 2 
He had experienced breathlessness on exertion with a 
dry cough for 2 weeks; however, his symptoms had 
worsened despite a course of oral antibiotics.  
Clinical data 3 
The patient had no significant medical history, led an 
active lifestyle and was a non-smoker. 
Clinical data 4 
On admission to hospital, he was dyspnoeic at rest 
with no complaints of chest pain, haemoptysis or calf 
tenderness.  
Clinical data 5 
On examination, the patient was tachypnoeic 
(respiratory rate, 32) and tachycardic (heart rate, 
120), saturating at 78% on air with a stable blood 
pressure (130/37 mm Hg).  
Clinical data 6 
On auscultation of the lungs, bilateral coarse crackles 
were audible. 
 
Classification  
International Classification of Diseases   
http://apps.who.int/classifications/icd10/browse/2016/en#/J45 
• IX Diseases of the circulatory system 
(I00-I99) 
• Pulmonary heart disease and diseases of 
pulmonary circulation 
(I26-I28) 
• 126 Pulmonary embolism 
• 126.0 Pulmonary embolism with mention 
of acute cor pulmonale 
• 126.9 Pulmonary embolism without 
mention of acute cor pulmonale. 
Classification                                                
Risk Groups 
http://eurheartj.oxfordjournals.org/content/35/43/3033 ifeinthefastlane.com/pulmonary-embolus-pondering/ 
• High risk (previously ‘massive’) PE 
patients have persistent shock or 
hypotension  
• Intermediate risk (previously ‘sub-
massive’) PE is defined as the 
presence of right ventricular (RV) 
dysfunction and/or myocardial 
injury in the absence of 
hypotension  
• Low risk PE patients have none of 
these features and can probably 
be treated outside of hospital. 
Symptoms and Signs 
Symptoms of pulmonary embolism are typically sudden in 
onset and may include one or many of the following:  
• Dyspnea (shortness of breath) 
• Tachypnea (rapid breathing) 
• Chest pain of a "pleuritic" nature (worsened by breathing)  
• Cough  
• Hemoptysis (coughing up blood) 
• Cyanosis (blue discoloration, usually of the lips and fingers) 
• Collapse 
• Circulatory instability because of decreased blood flow 
through the lungs and into the left side of the heart.   
https://en.wikipedia.org/wiki/Pulmonary_embolism#Signs_and_symptoms 
History 1 
• Most DVTs start in the calf, and most probably 
resolve spontaneously 
• Thrombi that remain confined to the calf rarely 
cause leg symptoms or symptomatic PE 
• The probability that calf DVT will extend to involve 
the proximal veins and subsequently cause PE 
increases with the severity of the initiating 
prothrombotic stimulus  
http://circ.ahajournals.org/content/107/23_suppl_1/I-22 
History 2 
• Although acute VTE usually presents with either leg 
or pulmonary symptoms, most patients have 
thrombosis at both sites at the time of diagnosis 
• Proximal DVTs resolve slowly during treatment with 
anticoagulants, and thrombi remain detectable in 
half of the patients after a year 
• Resolution of DVT is less likely in patients with a 
large initial thrombus or cancer  
http://circ.ahajournals.org/content/107/23_suppl_1/I-22 
History 3 
• 10% of patients with symptomatic DVTs develop 
severe post-thrombotic syndrome within 5 years 
• 10% of PEs are rapidly fatal, and an additional 5% 
cause death later, despite diagnosis and treatment 
• 50% of diagnosed PEs are associated with right 
ventricular dysfunction, which is associated with a 
≈5-fold greater in-hospital mortality  
http://circ.ahajournals.org/content/107/23_suppl_1/I-22 
History 4 
• There is ≈50% resolution of PE after 1 month of 
treatment, and perfusion eventually returns to 
normal in two thirds of patients 
• 5% of treated patients with PE develop pulmonary 
hypertension as a result of poor resolution 
• After a course of treatment, the risk of recurrent 
thrombosis is higher in patients without reversible 
risk factors. 
http://circ.ahajournals.org/content/107/23_suppl_1/I-22 
Physical Examination 1 
• The lungs are usually normal 
• Occasionally, a pleural friction rub may be audible 
over the affected area of the lung (mostly in PE 
with infarct) 
• A pleural effusion is sometimes present that is 
exudative, detectable by decreased percussion 
note, audible breath sounds, and vocal resonance  
http://emedicine.medscape.com/article/167981-clinical#b2 
Physical Examination 2 
• Strain on the right ventricle may be detected as a 
left parasternal heave, a loud pulmonary 
component of the second heart sound, and/or 
raised jugular venous pressure 
• A low-grade fever may be present, particularly if 
there is associated pulmonary hemorrhage or 
infarction   
• The chest X-ray is frequently abnormal and, 
although its findings are usually non-specific in PE 
http://emedicine.medscape.com/article/167981-clinical#b2 
Physical Examination 3 
• As smaller PE tend to lodge in more peripheral 
areas without collateral circulation they are more 
likely to cause lung infarction and small effusions 
(both of which are painful), but not hypoxia, 
dyspnea or hemodynamic instability such as 
tachycardia 
• Larger PEs, which tend to lodge centrally, typically 
cause dyspnea, hypoxia, low blood pressure, fast 
heart rate and fainting, but are often painless 
because there is no lung infarction due to collateral 
circulation  
http://emedicine.medscape.com/article/167981-clinical#b2 
Physical Examination 4 
• The classic presentation for PE with pleuritic pain, 
dyspnea and tachycardia is likely caused by a large 
fragmented embolism causing both large and small 
PEs 
• Small PEs are often missed because they cause 
pleuritic pain alone without any other findings and 
large PEs often missed because they are painless 
and mimic other conditions . 
http://emedicine.medscape.com/article/167981-clinical#b2 
Physical Examination 5                        
Massive Pulmonary Embolism 
• Patients with massive pulmonary embolism are in shock 
and have systemic hypotension, poor perfusion of the 
extremities, tachycardia, and tachypnea 
• In addition, patients appear weak, pale, sweaty, and 
oliguric and develop impaired mentation 
• Massive pulmonary embolism has been defined by 
hemodynamic parameters and evidence of myocardial 
injury rather than anatomic findings because the former is 
associated with adverse outcomes  
• Anatomic findings by computer tomography (CT) scan may 
be important in assessing risk in hemodynamically stable 
patients with pulmonary embolus. http://emedicine.medscape.com/article/300901-clinical#showall 
Physical Examination  6                       
Acute Pulmonary Infarction 
• Approximately 10% of patients have peripheral occlusion of 
a pulmonary artery, causing parenchymal infarction 
• These patients present with acute onset of pleuritic chest 
pain, breathlessness, and hemoptysis 
• Although the chest pain may be clinically indistinguishable 
from ischemic myocardial pain, normal electrocardiography  
findings and no response to nitroglycerin rules out 
myocardial pain 
• Patients with acute pulmonary infarction have decreased 
excursion of the involved hemithorax, palpable or audible 
pleural friction rub, and even localized tenderness 
• Signs of pleural effusion may be present. 
http://emedicine.medscape.com/article/300901-clinical#showall 
Physical Examination 7                        
Acute Embolism without Infarction 
• Patients with acute embolism without infarction have 
nonspecific physical signs that may easily be secondary to 
another disease process 
• Tachypnea and tachycardia frequently are detected, 
pleuritic pain sometimes may be present, crackles may be 
heard in the area of embolization, and local wheeze may be 
heard rarely. 
http://emedicine.medscape.com/article/300901-clinical#showall 
Physical Examination  8                       
Multiple Pulmonary Emboli or Thrombi 
• Patients with pulmonary emboli and thrombi have physical 
signs of pulmonary hypertension and cor pulmonale 
• Patients may have elevated jugular venous pressure, right 
ventricular heave, palpable impulse in the left second 
intercostal space, right ventricular S3 gallop, systolic 
murmur over the left sternal border that is louder during 
inspiration, hepatomegaly, ascites, and dependent pitting 
edema 
• These findings are not specific for pulmonary embolism 
and require a high index of suspicion for pursuing 
appropriate diagnostic studies. 
http://emedicine.medscape.com/article/300901-clinical#showall 
Complications 
http://www.webmd.com/lung/tc/pulmonary-embolism-what-happens 
• Cardiac arrest and sudden death 
• Shock 
• Abnormal heart rhythms 
• Pulmonary infarction 
• Pleural effusion  
• Paradoxical embolism 
• Pulmonary hypertension. 
Diagnosis 1                                           
Clinical Presentation 1   
• PE may escape prompt diagnosis since the clinical 
signs and symptoms are non-specific  
• When the clinical presentation raises the suspicion 
of PE in an individual patient, it should prompt 
further objective testing 
• In most patients, PE is suspected on the basis of 
dyspnea, chest pain, pre-syncope or syncope, 
and/or hemoptysis 
• Knowledge of the predisposing factors for VTE is 
important in determining the likelihood of PE  
 http://eurheartj.oxfordjournals.org/content/35/43/3033 
Diagnosis 2                                           
Clinical Presentation 2   
• In blood gas analysis, hypoxemia is considered a 
typical finding in acute PE, but up to 40% of the 
patients have normal arterial oxygen saturation and 
20% a normal alveolar-arterial oxygen gradient 
• Electrocardiographic changes indicative of RV strain, 
and incomplete or complete right bundle-branch 
block, may be helpful ; atrial arrhythmias, may be 
associated with acute PE. 
 
http://eurheartj.oxfordjournals.org/content/35/43/3033 
Diagnosis  3                                          
Electrocardiographic Changes    
Sinus tachycardia, simultaneous T-wave inversions in the 
anterior (V1-4) and inferior leads (II, III, aVF), non-specific ST 
changes – slight ST elevation in III and aVF. 
http://lifeinthefastlane.com/ecg-library/pulmonary-embolism/ 
Diagnosis 4                                           
Assessment Of Clinical Probability 
• Despite the limited sensitivity and specificity of individual 
symptoms, signs, and common tests, the combination of 
findings evaluated by clinical judgement or by the use of 
prediction rules allows to classify patients with suspected 
PE into distinct categories of clinical or pre-test probability 
that correspond to an increasing actual prevalence of 
confirmed PE 
• As the post-test (e.g. after computed tomography) 
probability of PE depends not only on the characteristics of 
the diagnostic test itself but also on pre-test probability, 
this has become a key step in all diagnostic algorithms for 
PE. 
http://eurheartj.oxfordjournals.org/content/35/43/3033 
Diagnosis 5                                           
Clinical Probability Scoring: The Wells’ Score  
http://img.medscape.com/fullsize/migrated/575/056/path575056.tab1.gif 
Diagnosis 6                                                  
D-dimer Testing 
• D-dimer levels are elevated in plasma in the presence of 
acute thrombosis because of simultaneous activation of 
coagulation and fibrinolysis 
• The negative predictive value of D-dimer testing is high and 
a normal D-dimer level renders acute PE or DVT unlikely 
• On the other hand, fibrin is also produced in a wide variety 
of conditions such as cancer, inflammation, bleeding, 
trauma, surgery and necrosis 
• Accordingly, the positive predictive value of elevated D-
dimer levels is low and D-dimer testing is not useful for 
confirmation of PE.  
http://eurheartj.oxfordjournals.org/content/35/43/3033 
Diagnosis  7                                                 
Computed Tomographic Pulmonary Angiography 
• Since the introduction of multi-detector computed 
tomographic (MDCT) angiography with high spatial and 
temporal resolution and quality of arterial opacification, CT 
angiography has become the method of choice for imaging 
the pulmonary vasculature in patients with suspected PE 
• It allows adequate visualization of the pulmonary arteries 
down to at least the segmental level. 
http://eurheartj.oxfordjournals.org/content/35/43/3033 
Diagnosis   8                                          
Multi-detector Computed Tomographic Angiography 
Pulmonary emboli in the middle and in the anterior branches 
of the left lung (arrow), and several lung nodules in both 
lungs. 
https://www.researchgate.net/figure/42343864_fig5_Figure-6-Pulmonary-computed-tomography-angiography-images-demonstrated-pulmonary-emboli 
Diagnosis 9                                                  
Lung Scintigraphy 
• Ventilation–perfusion scintigraphy (V/Q scan) is an 
established diagnostic test for suspected PE 
• V/Q scan is safe and few allergic reactions have been 
described 
• The test is based on the intravenous injection of 
technetium (Tc)-99m-labelled macroaggregated albumin 
particles, which block a small fraction of the pulmonary 
capillaries and thereby enable scintigraphic assessment of 
lung perfusion 
• Perfusion scans are combined with ventilation studies, for 
which multiple tracers such as xenon-133 gas, Tc-99m-
labelled aerosols can be used  
http://eurheartj.oxfordjournals.org/content/35/43/3033 
Diagnosis  10                                           
Ventilation–perfusion Scintigraphy  
An abnormal nuclear lung scan shows areas without nuclear 
particles (arrows). This finding indicates that pulmonary 
emboli (blood clots) may be present. A normal lung scan is 
shown on the right for comparison. 
http://web.carteret.edu/keoughp/LFreshwater/CPAP/V-Q%20Relationships/VQClassNotes.htm 
Diagnosis  11                                                 
Pulmonary Angiography 1 
• Pulmonary angiography has for decades remained 
the ‘gold standard' for the diagnosis or exclusion of 
PE, but is rarely performed now as less-invasive CT 
angiography offers similar diagnostic accuracy 
• The diagnosis of acute PE is based on direct 
evidence of a thrombus in two projections, either as 
a filling defect or as amputation of a pulmonary 
arterial branch  
http://eurheartj.oxfordjournals.org/content/35/43/3033 
Diagnosis   12                                                
Pulmonary Angiography 2 
• Thrombi as small as 1–2 mm within the sub-
segmental arteries can be visualized , but there is 
substantial inter-observer variability at this level 
• Indirect signs of PE, such as slow flow of contrast, 
regional hypoperfusion, and delayed or diminished 
pulmonary venous flow, are not validated and 
hence are not diagnostic.   
http://eurheartj.oxfordjournals.org/content/35/43/3033 
Diagnosis  13                                           
Pulmonary angiography as the ‘gold standard' for the 
diagnosis or exclusion of PE 
Organized thrombi appear as unusual filling defects, 
webs, or bands, or completely thrombosed vessels 
that may resemble congenital absence of the vessel. 
http://web.carteret.edu/keoughp/LFreshwater/CPAP/V-Q%20Relationships/VQClassNotes.htm 
Diagnosis 14                                                  
Magnetic Resonance Angiography 
• Magnetic resonance angiography (MRA) has been 
evaluated for several years in suspected PE but large-scale 
studies were published only recently 
• Their results show that this technique, although promising, 
is not yet ready for clinical practice due to its low 
sensitivity, high proportion of inconclusive MRA scans, and 
low availability in most emergency settings . 
http://eurheartj.oxfordjournals.org/content/35/43/3033 
Diagnosis 15                                                   
Echocardiography 
• Acute PE may lead to right ventricle (RV) pressure overload and 
dysfunction, which can be detected by echocardiography  
• Given the peculiar geometry of the RV, there is no individual 
echocardiographic parameter that provides fast and reliable 
information on RV size or function 
• Signs of RV overload or dysfunction may also be found in the absence 
of acute PE and be due to concomitant cardiac or respiratory disease. 
http://eurheartj.oxfordjournals.org/content/35/43/3033 
Diagnosis  16                                           
Echocardiography Signs 
A patient with acute pulmonary thromboembolism. In the 
diastole, the ratio of the right ventricular end-diastolic area 
to left ventricular end-diastolic area was more than 1.0 which 
is consistent with severe right ventricular dysfunction (normal 
value is less than 0.6). 
https://synapse.koreamed.org/DOIx.php?id=10.4250/jcu.2008.16.1.9&vmode=PUBREADER 
Diagnosis 17                                                  
Validated Diagnostic Criteria 
http://eurheartj.oxfordjournals.org/content/35/43/3033 
Investigations 1 
The patient's blood results showed elevated white 
blood cells (18×109/l), C reactive protein (128 mg/l) 
and an arterial blood gas taken at room air showed an 
evidence of type 1 respiratory failure (pH 7.43, 
pO2 7.3 kPa, pCO2 4 kPa). 
Investigations 2 
A portable chest 
x-ray revealed 
patchy 
shadowing and 
ECG showed 
sinus tachycardia 
with right heart 
strain. 
Posterior anterior chest x-
ray showing dense 
consolidation in the left 
upper zone with patchy 
consolidation in the left 
lower and right upper zone. 
Investigations 3 
Despite 15 litres oxygen, the patient 
remained breathless and hypoxic 
(oxygen saturations of 83%).  
On further questioning, he 
mentioned that his first cousin had 
suffered a pulmonary saddle 
embolism and had been diagnosed 
with protein S deficiency.  
This had prompted other family 
members to have a thrombophilia 
screen and the patient had also 
been found to be protein S 
deficient. 
Family tree.  
Orange individuals have had a venous 
thromboembolism.  
Green individuals have been screened 
positive for protein S deficiency.  
Red indicates the patient in question. 
Investigations 4 
An urgent CT 
pulmonary 
angiogram was 
requested at 
04:30 h, which 
showed an evidence 
of extensive bilateral 
pulmonary emboli 
and right ventricular 
strain. 
CT pulmonary angiogram on admission: (A) blue arrows 
showing bilateral upper lobe pulmonary segmental 
emboli; (B) blue arrows showing segmental emboli in the 
right and left lower lobe pulmonary artery branches. Red 
arrows showing consolidation in the left lung. 
Diagnosis 18                                                   
Differentiation 1 
• Acute Coronary Syndrome 
• Acute Pericarditis 
• Acute Respiratory Distress 
Syndrome 
• Angina Pectoris 
• Anxiety Disorders 
• Aortic Stenosis 
 
• Atrial Fibrillation 
• Cardiogenic Shock 
• Cor Pulmonale 
• Dilated Cardiomyopathy 
• Emphysema 
• Fat Embolism 
http://emedicine.medscape.com/article/300901-differential 
Diagnosis 19                                                   
Differentiation 2 
• Hypersensitivity Pneumonitis 
• Mitral Stenosis 
• Myocardial Infarction 
• Pneumothorax Imaging 
• Pulmonary Arterial 
Hypertension 
• Pulmonary Arteriovenous 
Fistulae 
• Restrictive 
Cardiomyopathy  
• Sudden Cardiac Death 
• Superior Vena Cava 
Syndrome in Emergency 
Medicine 
• Syncope 
http://emedicine.medscape.com/article/300901-differential 
Differential diagnosis  
• Due to the degree of hypoxia, family history of thrombophilia and right 
heart strain, massive pulmonary embolism remained the most likely 
diagnosis. 
• Other differentials were also considered, such as the original diagnosis of 
community-acquired pneumonia due to the patchy shadowing seen on the 
chest x-ray. This did not explain the significant hypoxia despite high-flow 
oxygen and the patient did not have fever or a productive cough. 
• A patient presenting with shortness of breath and low oxygen saturations 
raises the possibility of a pneumothorax, but clinical examination and chest 
x-ray did not correlate with this diagnosis. 
• Importantly, cardiac causes such as an inherited cardiomyopathy or 
connective tissue disease causing acute valvular pathology or dissection 
should remain a high differential diagnosis. Although ECG showed right 
heart strain, the patient did not experience chest pain or syncope and had 
no phenotypical features of a connective tissue disorder on examination. 
Management 1   
• Anticoagulant therapy is the mainstay of treatment 
• Acutely, supportive treatments, such 
as oxygen or analgesia, may be required 
• People are often admitted to hospital in the early 
stages of treatment, and tend to remain under 
inpatient care until the international normalized 
ratio (INR) has reached therapeutic levels 
• Low-risk cases are managed at home in a fashion 
already common in the treatment of DVT 
• Evidence to support one approach versus the other 
is weak. 
https://en.wikipedia.org/wiki/Pulmonary_embolism#Diagnosis 
Management  2                                  
Anticoagulation 1  
• Anticoagulant therapy is the mainstay of treatment 
(heparin, low molecular weight heparin (LMWH), 
fondaparinux, warfarin, acenocoumarol, 
or phenprocoumon) 
• LMWH may reduce bleeding among people with 
pulmonary embolism as compared to heparin  
• Warfarin therapy often requires a frequent dose 
adjustment and monitoring of the INR: INRs 
between 2.0 and 3.0 are generally considered ideal  
https://en.wikipedia.org/wiki/Pulmonary_embolism#Diagnosis 
Management  3                                  
Anticoagulation 2  
• In patients with an underlying malignancy, therapy 
with a course of LMWH is favored over warfarin  
• Similarly, pregnant women are often maintained on 
low molecular weight heparin until at least six 
weeks after delivery to avoid the known 
teratogenic effects of warfarin, especially in the 
early stages of pregnancy.  
https://en.wikipedia.org/wiki/Pulmonary_embolism#Diagnosis 
USMLE Step 2 CK` test 1 
A 65-year-old woman who recently underwent hip 
replacement comes to the emergency department with 
the acute onset of shortness of breath and tachycardia. 
The chest x-ray is normal, with hypoxia on ABG, an 
increased A-a gradient, and an EKG with sinus 
tachycardia.  
What is the most appropriate next step in management?  
A. Intravenous unfractionated heparin, B. Thrombolytics  
Inferior vena cava filter, C. Embolectomy, D. Spiral CT 
scan, E. Ventilation/perfusion (V/Q) scan, F. Lower-
extremity, G. Doppler studies, H. 0-dimer 
usmle-forums.com/usmle-step-2-ck-forum/16583-five-pulmonology-questions-part-2-a.html 
Management  4                                  
Thrombolysis   
• Massive PE causing hemodynamic instability is an indication 
for thrombolysis, the enzymatic destruction of the clot with 
medication 
• Catheter-directed thrombolysis (CDT) is a new technique 
found to be relatively safe and effective for massive Pes 
• Medication that breaks up blood clots is released through 
the catheter so that its highest concentration is directly next 
to the pulmonary embolus 
• CDT is performed by interventional radiologists, and in 
medical centers that offer CDT, it should be considered first-
line treatment  
• The use of thrombolysis in non-massive PEs is still debated.  
https://en.wikipedia.org/wiki/Pulmonary_embolism#Diagnosis 
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Inferior Vena Cava Filter 1   
• There are two situations when an inferior vena cava 
filter is considered advantageous, and those are if 
anticoagulant therapy is contraindicated (e.g. 
shortly after a major operation), or a person has a 
pulmonary embolus in spite of being anticoagulated  
• In these instances, it may be implanted to prevent 
new or existing DVTs from entering the pulmonary 
artery and combining with an existing blockage   
https://en.wikipedia.org/wiki/Pulmonary_embolism#Diagnosis 
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Inferior Vena Cava Filter 2 
• Inferior vena cava filters should be removed as soon 
as it becomes safe to start using anticoagulation. 
• Although modern filters are meant to be retrievable, 
complications may prevent some from being 
removed 
• The long-term safety profile of permanently leaving 
a filter inside the body is not known. 
https://en.wikipedia.org/wiki/Pulmonary_embolism#Diagnosis 
USMLE Step 2 CK` test 2 
A 29-year-old man comes to the emergency department because of the acute 
onset of dyspnea and pleuritic chest pain for the last 2 hours. He has a known 
history of Factor V Leiden deficiency. His condition was discovered 4 months 
prior, when he suffered a pulmonary embolus and was placed on warfarin. 
Aside from this condition and its complications, his past medical history is 
unremarkable. Currently his vital signs are: temperature 37.0 C, blood pressure 
150/95 mm Hg, pulse 112/min, respirations 30/min, and oxygen saturation 
97%. Chest examination reveals some diffuse crackles at the right base. A CT-
angiogram shows two small filling defects in the right lower lobe pulmonary 
vasculature. STAT (urgent) coagulation laboratory studies reveal an INR of 3.2 
and an activated Partial Thromboplastin Time (aPPT)of 28 seconds. In addition 
to starting heparin, which of the following is an appropriate management for 
this patient? 
A. Add aminocaproic acid, B. Begin thrombolytic therapy, C. Increase the dose 
of warfarin, D. Send him for a thrombectomy, E. Surgically place an inferior 
vena cava filter 
usmle-forums.com/usmle-step-2-ck-forum/16583-five-pulmonology-questions-part-2-a.html 
Management  7                                   
Surgery   
• Surgical management of acute PE (pulmonary 
thrombectomy) is uncommon and has largely been 
abandoned because of poor long-term outcomes 
• However, recently, it has gone through a resurgence with 
the revision of the surgical technique and is thought to 
benefit certain people 
• Chronic PE leading to pulmonary hypertension (known 
as chronic thromboembolic hypertension) is treated with a 
surgical procedure known as a pulmonary 
thromboendarterectomy. 
https://en.wikipedia.org/wiki/Pulmonary_embolism#Diagnosis 
Treatment 1 
Following the diagnosis of 
massive pulmonary embolism, 
the patient was thrombolysed at 
04:50 h with alteplase (10 mg 
given as an intravenous bolus, 
followed by an intravenous 
infusion of 90 mg over 2 h). He 
was moved to the intensive care 
unit for 24 h observation and his 
oxygen saturations improved 
almost instantly. 
CT pulmonary angiogram post-
thrombolysis blue arrows showing 
minimal residual emboli and red arrows 
showing resolution of consolidation. 
Treatment 2 
He remained 
haemodynamically 
stable and was 
transferred to the 
respiratory ward. A 
repeated CT 
pulmonary angiogram 
showed almost 
complete resolution 
of emboli. 
Oxygen saturations in accident and emergency with 
pre-thrombolysis and post-thrombolysis. 
Outcome and follow-up 1 
The benefits of life-long warfarin greatly outweighed 
the risks for this patient, as the chance of thrombosis 
recurrence within a year is greater than 9%. 
This was discussed with the patient, who agreed to 
begin warfarin therapy life-long. The side effects of 
warfarin and the need for regular blood tests were 
also discussed. 
Outcome and follow-up 2 
Any chronic condition that is life threatening may 
cause a significant amount of psychological stress.  
As the patient was ordinarily very active, it was made 
clear that exercise is still beneficial and should not be 
avoided due to anxieties over medication or disease 
recurrence.  
He has also been offered genetic counselling advice in 
the future, should he wish to start a family. 
Outcome and follow-up 3 
As a vegetarian, the patient was advised on the 
vitamin K content of certain foods.  
He was also warned about the risk of thrombosis in 
periods of immobility and advised to wear 
compression stockings during long-haul flights. 
Outcome and follow-up 2 
Any chronic condition that is life threatening may 
cause a significant amount of psychological stress.  
As the patient was ordinarily very active, it was made 
clear that exercise is still beneficial and should not be 
avoided due to anxieties over medication or disease 
recurrence.  
He has also been offered genetic counselling advice in 
the future, should he wish to start a family. 
Prognosis 
 
• Less than 5 to 10% of symptomatic PEs are fatal 
within the first hour of symptoms  
• Prognosis depends on the amount of lung that is 
affected and on the co-existence of other medical 
conditions; chronic embolization to the lung can 
lead to pulmonary hypertension 
• Once anticoagulation is stopped, the risk of a fatal 
pulmonary embolism is 0.5% per year  
• Mortality from untreated PEs was said to be 26%.   
https://en.wikipedia.org/wiki/Pulmonary_embolism#Diagnosis 
Prophylaxis 
• PE may be preventable in those with risk factors 
• People admitted to hospital may receive 
preventative medication, including 
unfractionated heparin, low molecular weight 
heparin, or fondaparinux, and anti-thrombosis 
stockings to reduce the risk of a DVT in the leg that 
could dislodge and migrate to the lungs  
• Following the completion of warfarin in those with 
prior PE, long-term aspirin is useful to prevent 
recurrence. 
https://en.wikipedia.org/wiki/Pulmonary_embolism#Diagnosis 
Abbreviations  
aPPT - activated partial thromboplastin time  
DVT - deep venous thrombosis  
CDT - catheter-directed thrombolysis  
CT - computed tomography  
CTEPH - chronic thromboembolic pulmonary hypertension  
INR - international normalized ratio  
LMWH - low molecular weight heparin  
MDCT - multi-detector computed tomography 
MRA - magnetic resonance angiography  
PE - pulmonary embolism 
RV - right ventricle  
VTE - venous thromboembolism 
V/Q scan - ventilation–perfusion scintigraphy 
Diagnostic and treatment guidelines 
Acute pulmonary embolism  
2014 ESC Guidelines on the diagnosis and management of acute 
pulmonary embolism 
Pulmonary Embolism Guidelines 
Pulmonary Embolism Treatment & Management 
Management of Massive and Submassive Pulmonary Embolism, 
Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic 
Pulmonary Hypertension 
Evaluation of Patients With Suspected Acute Pulmonary Embolism: Best 
Practice Advice From the Clinical Guidelines Committee of the American 
College of Physicians 
 
 
 
